{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:53:37Z","timestamp":1773258817381,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Cross\u2010sectional studies have shown impaired quality of life (QoL) in patients in biochemical control of acromegaly. The aim of this study was to assess longitudinal changes in QoL in a homogenous cohort of patients with sustained biochemical control of acromegaly.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Prospective follow\u2010up study.<\/jats:p><jats:p><jats:bold>Patients and methods\u2002<\/jats:bold> QoL was assessed using four health\u2010related QoL questionnaires (HADS, Hospital Anxiety and Depression Scale; MFI\u201020, Multidimensional Fatigue Index; NHP, Nottingham Health Profile; and SF\u201036, Short Form\u201036) and one disease\u2010specific acromegaly quality of life (ACRO\u2010QOL) questionnaire in 82 patients (43 men) with strict biochemical control of acromegaly, aged 56\u00a0years (range 29\u201384\u00a0years) at baseline and after 4\u00a0years of follow\u2010up. The mean duration of controlled disease was 12\u00a0years (range 1\u201326\u00a0years).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> During follow\u2010up, scores in 5 of 26 QoL subscales significantly worsened: physical and social functioning (SF\u201036), physical fatigue (MFI\u201020), and psychological well\u2010being and personal relations (ACRO\u2010QOL). Using linear regression analysis, baseline item scores predicted the follow\u2010up scores, indicating individual stability over time. Previous radiotherapy (<jats:italic>n<\/jats:italic>\u00a0=\u00a027, 33%) negatively influenced several QoL subscales at follow\u2010up: energy, pain and social isolation (NHP), physical fatigue and reduction in activity and motivation (MFI\u201020), depression and total anxiety and depression scores (HADS) and physical performance (ACRO\u2010QOL).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> During 4\u00a0years of follow\u2010up in patients with long\u2010term biochemical control of ACRO\u2010QOL is subtly, but progressively impaired. Radiotherapy was the predominant indicator of progressive impairment in QoL.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2007.03169.x","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T13:20:22Z","timestamp":1213708822000},"page":"123-128","source":"Crossref","is-referenced-by-count":64,"title":["Previous radiotherapy negatively influences quality of life during 4 years of follow\u2010up in patients cured from acromegaly"],"prefix":"10.1111","volume":"69","author":[{"given":"Agatha A.","family":"Van Der Klaauw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrieke C.","family":"Hoftijzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes A.","family":"Romijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","author":"Wright A.D.","year":"1970","journal-title":"Quarterly Journal of Medicine"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1191"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.6.14.2393"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63011-5"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra062453"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06844-1"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02292"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0676"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02307.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02214"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1565"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0669"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02891.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)00125-O"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.34.4.281"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.1980.tb00213.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6846.160"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01597.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.7.2476"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.1.129"},{"key":"e_1_2_6_24_2","first-page":"45","article-title":"The LMS method for constructing normalized growth standards","volume":"44","author":"Cole T.J.","year":"1990","journal-title":"European Journal of Clinical Nutrition"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023268"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-2096-4"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1375"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.186"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2007.03169.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2007.03169.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:34:26Z","timestamp":1697229266000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2007.03169.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1365-2265.2007.03169.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03169.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}